Subscription

Service

Need more than one report? Subscribe to Key Note today for immediate access to market research, company information, a unique bespoke report generator and our easy to use sales leads builder. Request a free online demo

Key Note Media Centre

Press Releases

Contraception Market Unscathed by Recession...

Article Date

02
11
11


According to Contraception, a new Market Report by Market Intelligence provider Key Note, the contraception market remained resilient during the recent economic downturn. Key Note estimates that the UK contraception market grew by 14% between 2006 and 2010 to £190.9m.

In terms of sector, growth in the market for hormone-based products has been the strongest, increasing by an estimated 27.2% between 2006 and 2010, followed by the market for intra-uterine products, which grew by 19%. In contrast, the market for condoms and spermicides has declined over the same period.

Meanwhile, data from the Health Protection Agency (HPA) indicates that the number of sexually transmitted infections (STIs) diagnoses appears to be slowing. In 2010, the number of new STI diagnoses in England decreased by 1.5% on the previous year. However, the number of herpes and gonorrhoea diagnoses continued to increase between 2008 and 2010, by 13.8% and 10.3%, respectively, while the number of chlamydia diagnoses appeared to stabilise in 2010. The number of diagnoses for syphilis, genital warts and non-specific genital infection showed a year-on-year decline over the same period.

Key Note suggests that demographic trends, such as the ageing of the UK's population, and a decline in the number of those in younger age-groups is likely to have a negative impact on the market for oral contraceptives and condoms, but will drive the demand for long acting reversible contraceptives (LARCs), as well as surgical contraceptive methods.

The UK Government has been keen to promote sexual health and is currently working to allow easy access to sexual health services, including services for sexually transmitted infections, contraception and abortions, which is expected to benefit the contraception market.

Key Note forecasts that the UK market for contraception will grow by 17.7% between 2011 and 2015 to £233.5m.

 

 

View FREE Executive Summary & Table of Contents for Contraception

 

 

Press enquiries: Jack Sykes at Key Note at jsykes@keynote.co.uk or 0845 504 0452. Press/review copies of the report are available on request.